References 1. Siegel JD, Rhinehart E, Jackson M, Chiarello L, The Healthcare Infection Control Practices Advisory Committee. Management of Multidrug-Resistant Organisms In Healthcare Settings. 2006. 2. European commission. A European one health action plan against antimicrobial resistance (AMR). 2017. 3. Cassini A, Högberg LD, Plachouras D, Quattrocchi A, Hoxha A, Simonsen GS, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. The Lancet Infectious Diseases. 2019;19(1):56-66. 4. Organisation for Economic Co-operation and Development, European Centre for Disease Prevention and Control. Antimicrobial Resistance. Tackling the Burden in the European Union. Briefing note for EU/EEA countries. Paris: Organisation for Economic Co-operation and Development; 2019. 5. Weterings V, Veenemans J, van Rijen M, Kluytmans J. Prevalence of nasal carriage of methicillin-resistant Staphylococcus aureus in patients at hospital admission in The Netherlands, 2010-2017: an observational study. Clin Microbiol Infect. 2019;25(11):1428 e1- e5. 6. Wielders CCH, van Hoek A, Hengeveld PD, Veenman C, Dierikx CM, Zomer TP, et al. Extended-spectrum β-lactamase- and pAmpC-producing Enterobacteriaceae among the general population in a livestock-dense area. Clin Microbiol Infect. 2017;23(2):120 e1- e8. 7. Reuland EA, Al Naiemi N, Kaiser AM, Heck M, Kluytmans JA, Savelkoul PH, et al. Prevalence and risk factors for carriage of ESBL-producing Enterobacteriaceae in Amsterdam. J Antimicrob Chemother. 2016;71(4):1076-82. 8. van den Bunt G, van Pelt W, Hidalgo L, Scharringa J, de Greeff SC, Schürch AC, et al. Prevalence, risk factors and genetic characterisation of extended-spectrum beta-lactamase and carbapenemase-producing Enterobacteriaceae (ESBL-E and CPE): a community-based cross-sectional study, the Netherlands, 2014 to 2016. Euro Surveill. 2019;24(41). 9. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care setting. American Journal of Infection Control. 2008;36(5):309-32. 10. Altimier LB. Healing environments: for patients and providers. Newborn and Infant Nursing Reviews. 2004;4(2):89-92. 11. Kamali NJ, Abbas MY. Healing Environment: Enhancing Nurses’ Performance through Proper Lighting Design. Procedia - Social and Behavioral Sciences. 2012;35:205-12. 12. Ulrich RS, Zimring C, Zhu X, DuBose J, Seo H-B, Choi Y-S, et al. A Review of the Research Literature on Evidence-Based Healthcare Design. HERD: Health Environments Research & Design Journal. 2008;1(3):61-125. 13. Chaudhury H, Mahmood A, Valente M. Nurses' perception of single-occupancy versus multioccupancy rooms in acute care environments: An exploratory comparative assessment. Applied Nursing Research. 2006;19(3):118-25. 14. Stiller A, Salm F, Bischoff P, Gastmeier P. Relationship between hospital ward design and healthcare-associated infection rates: a systematic review and meta-analysis. Antimicrob Resist Infect Control. 2016;5:51. 15. Hamel M, Zoutman D, O'Callaghan C. Exposure to hospital roommates as a risk factor for health care-associated infection. Am J Infect Control. 2010;38(3):173-81. 16. Wu YL, Yang XY, Ding XX, Li RJ, Pan MS, Zhao X, et al. Exposure to infected/colonized roommates and prior room occupants increases the risks of healthcare-associated infections with the same organism. J Hosp Infect. 2019;101(2):231-9. 17. Bracco D, Dubois MJ, Bouali R, Eggimann P. Single rooms may help to prevent nosocomial bloodstream infection and cross-transmission of methicillin-resistant Staphylococcus aureus in intensive care units. Intensive Care Med. 2007;33(5):836-40. 1 19 General introduction
RkJQdWJsaXNoZXIy MTk4NDMw